GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cipher Pharmaceuticals Inc (TSX:CPH) » Definitions » Net Margin %

Cipher Pharmaceuticals (TSX:CPH) Net Margin % : 155.58% (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Cipher Pharmaceuticals Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Cipher Pharmaceuticals's Net Income for the three months ended in Dec. 2023 was C$10.27 Mil. Cipher Pharmaceuticals's Revenue for the three months ended in Dec. 2023 was C$6.60 Mil. Therefore, Cipher Pharmaceuticals's net margin for the quarter that ended in Dec. 2023 was 155.58%.

The historical rank and industry rank for Cipher Pharmaceuticals's Net Margin % or its related term are showing as below:

TSX:CPH' s Net Margin % Range Over the Past 10 Years
Min: -132.03   Med: 17.75   Max: 128.83
Current: 96.26


TSX:CPH's Net Margin % is ranked better than
99.22% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 3.76 vs TSX:CPH: 96.26

Cipher Pharmaceuticals Net Margin % Historical Data

The historical data trend for Cipher Pharmaceuticals's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cipher Pharmaceuticals Net Margin % Chart

Cipher Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.44 21.05 35.35 128.83 96.32

Cipher Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 400.91 53.74 58.07 115.87 155.58

Competitive Comparison of Cipher Pharmaceuticals's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Cipher Pharmaceuticals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cipher Pharmaceuticals's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cipher Pharmaceuticals's Net Margin % distribution charts can be found below:

* The bar in red indicates where Cipher Pharmaceuticals's Net Margin % falls into.



Cipher Pharmaceuticals Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Cipher Pharmaceuticals's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=27.346/28.391
=96.32 %

Cipher Pharmaceuticals's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=10.27/6.601
=155.58 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cipher Pharmaceuticals  (TSX:CPH) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Cipher Pharmaceuticals Net Margin % Related Terms

Thank you for viewing the detailed overview of Cipher Pharmaceuticals's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cipher Pharmaceuticals (TSX:CPH) Business Description

Traded in Other Exchanges
Address
5750 Explorer Drive, Suite 404, Mississauga, ON, CAN, L4W 0A9
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products among others. The company's geographical operational areas include Canada and the United States.

Cipher Pharmaceuticals (TSX:CPH) Headlines

No Headlines